Merck stops production of osteoporosis drug over stroke concerns, has yet to stop vaccine production

(NaturalNews) Pharmaceutical giant Merck announced on September 2 that it is abandoning plans for a new osteoporosis drug known as odanacatib, after the latest phase of safety trials showed that the drug significantly raised patients' risk of stroke. The findings of that trial will...

from NaturalNews.com http://ift.tt/2bZRheh